» Articles » PMID: 16473015

Mutant Huntingtin Aggregates Impair Mitochondrial Movement and Trafficking in Cortical Neurons

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2006 Feb 14
PMID 16473015
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by a polyglutamine repeat in the huntingtin gene (Htt). Mitochondrial defects and protein aggregates are characteristic of affected neurons. Recent studies suggest that these aggregates impair cellular transport mechanisms by interacting with cytoskeletal components and molecular motors. Here, we investigated whether mutant Htt alters mitochondrial trafficking and morphology in primary cortical neurons. We demonstrate that full-length mutant Htt was more effective than N-terminal mutant Htt in blocking mitochondrial movement, an effect that correlated with its heightened expression in the cytosolic compartment. Aggregates impaired the passage of mitochondria along neuronal processes, causing mitochondria to accumulate adjacent to aggregates and become immobilized. Furthermore, mitochondrial trafficking was reduced specifically at sites of aggregates while remaining unaltered in regions lacking aggregates. We conclude that in cortical neurons, an early event in HD pathophysiology is the aberrant mobility and trafficking of mitochondria caused by cytosolic Htt aggregates.

Citing Articles

Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration.

Liu D, Webber H, Bian F, Xu Y, Prakash M, Feng X Nat Commun. 2025; 16(1):1789.

PMID: 39979261 PMC: 11842812. DOI: 10.1038/s41467-025-57135-8.


Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons.

Dafinca R, Tosat-Bitrian C, Carroll E, Vahsen B, Gilbert-Jaramillo J, Scaber J Brain Commun. 2024; 6(5):fcae350.

PMID: 39440303 PMC: 11495216. DOI: 10.1093/braincomms/fcae350.


The role of the gut microbiota in neurodegenerative diseases targeting metabolism.

Fu Y, Gu Z, Cao H, Zuo C, Huang Y, Song Y Front Neurosci. 2024; 18:1432659.

PMID: 39391755 PMC: 11464490. DOI: 10.3389/fnins.2024.1432659.


Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology.

Kathiresan D, Balasubramani R, Marudhachalam K, Jaiswal P, Ramesh N, Sureshbabu S Mol Neurobiol. 2024; .

PMID: 39269547 DOI: 10.1007/s12035-024-04469-x.


Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration.

Tenchov R, Sasso J, Zhou Q ACS Chem Neurosci. 2024; 15(15):2665-2694.

PMID: 38996083 PMC: 11311141. DOI: 10.1021/acschemneuro.4c00184.